I-123 Biomarker Committee
Revision as of 19:15, 18 January 2019 by Jlisiecki (talk | contribs) (→Recent Meetings/Call Summaries)
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
- Co-chairs: John Dickson, PhD; John Seibyl, MD
- Secretary: Julie Lisiecki
Quantifying Dopamine Transporters with 123Iodine Labeled Ioflupane in Neurodegenerative Diseases
Recent Meetings/Call Summaries
Profile Development
Reference Materials
- QIBA SPECT I-123 Biomarker Committee Presentation (11.16.2018) John Seibyl, MD